A major focus of a U.S. Senate Caucus on International Narcotics Control hearing on the health impacts of marijuana turned out to be how cannabis’s current federal classification makes it harder for researchers to shed light on those effects. The Wednesday event—titled “Marijuana and America’s Health: Questions and Issues for Policy Makers”—featured testimony from Surgeon … Continue reading Senate Marijuana Hearing Highlights How Schedule I Status Blocks Research